-
Voliotis Dimitris
2023/04/10
SVP, Clinical Development
119563
-30601
2023-04-10
0001725160
0001725160
88962
-
Viking Global Opportunities Illiquid Investments Sub-Master LP
2023/04/09
1450000
-500000
2023-04-09
0001725160
0001725160
950000
-
Voliotis Dimitris
2023/04/08
SVP, Clinical Development
119563
-30601
2023-04-08
0001725160
0001725160
88962
-
Viking Global Opportunities Illiquid Investments Sub-Master LP
2023/04/07
1450000
-500000
2023-04-07
0001725160
0001725160
950000
-
Epperly Melissa B,
2023/04/06
Chief Financial Officer
459293
-94611
2023-04-06
0001725160
0001725160
364682
-
Ott David C.
2023/04/05
1450000
-500000
2023-04-05
0001725160
0001725160
950000
-
Viking Global Opportunities Illiquid Investments Sub-Master LP
2023/04/04
1450000
-500000
2023-04-04
0001725160
0001725160
950000
-
Voliotis Dimitris
2023/04/03
SVP, Clinical Development
119563
-30601
2023-04-03
0001725160
0001725160
88962
-
Voliotis Dimitris
2023/04/02
SVP, Clinical Development
119563
-30601
2023-04-02
0001725160
0001725160
88962
-
Viking Global Opportunities Illiquid Investments Sub-Master LP
2023/04/01
1450000
-500000
2023-04-01
0001725160
0001725160
950000